Abstract
Destruction of virus-infected cells in the absence of antibody (natural killer cytotoxicity [NKCD has been correlated with resistance to infection due to herpes simplex virus (HSV). Two preparations of human leukocyte interferon produced by recombinant DNA bacteria — IFLrA and IFLrD — were demonstrated to increase NKC in a dose-dependent fashion in vitro. IFLrA was more potent than was IFLrD in this assay. When administered intraperitoneally in combination with human leukocytes to one-week-old mice, IFLrA and IFLrD significantly increased survival (to 47.6% [PP < 0.05], respectively) after an otherwise uniformly lethal challenge of HSV. Differences between interferon immunostimulating activities at similar antiviral concentrations may be important in vivo in animals and in clinical settings.

This publication has 12 references indexed in Scilit: